Grading vulvar cancer

Last medical review:

Grading describes how the cancer cells look compared to normal, healthy cells. Knowing the grade gives your healthcare team an idea of how quickly the cancer may be growing and how likely it is to spread. This helps them plan your treatment. The grade can also help the healthcare team predict future outcomes (your prognosis) and how the cancer might respond to treatment. The grade is also used to stage vulvar cancer.

The most common type of vulvar cancer, squamous cell carcinoma (SCC) of the vulva, is usually not graded. Your healthcare team will look at whether the tumour is linked to a human papillomavirus (HPV) infection to understand how the cancer may behave.

Other types of vulvar cancer may still receive a grade. To find out the grade of vulvar cancer, the pathologist looks at a tissue sample from the vulva under a microscope. They look at how different the cells look from normal cells (called differentiation) and other features of the tumour such as the size and shape of the cells and how the cells are arranged. They can usually tell how fast a tumour is growing by looking at how many cells are dividing.

The pathologist gives vulvar cancer a grade from 1 to 3. A lower number means the cancer is a lower grade.

Low-grade cancers have cancer cells that are well differentiated. The cells are abnormal but look a lot like normal cells and are arranged a lot like normal cells. Lower grade cancers tend to grow slowly and are less likely to spread.

High-grade cancers have cancer cells that are poorly differentiated or undifferentiated. The cells don’t look like normal cells and are arranged very differently. Higher grade cancers tend to grow more quickly and are more likely to spread than low-grade cancers.

Expert review and references

  • Amy Jamieson, MBChB, FRANZCOG, CGO, FRCSC
  • Lien Hoang, MD
  • Cancer Research UK. Stages and Grades of Vulval Cancer. 2023. https://www.cancerresearchuk.org/.
  • Höhn AK, Brambs CE, Hiller GGR. 2020 WHO classification of female genital tumors. Geburtshilfe und Frauenheilkunde. 2021: 81(10):1145–1153.
  • National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Vulvar Cancer. Version 4.2024. 2024. https://www.nccn.org/home.
  • Olawaiye AB, Cuello MA, Rogers LJ. Cancer of the vulva: 2021 update. International Journal of Gynecology & Obstetrics. 2021: 155 Suppl 1(Suppl 1):7–18.

Your trusted source for accurate cancer information

With support from readers like you, we can continue to provide the highest quality cancer information for over 100 types of cancer.

We’re here to ensure easy access to accurate cancer information for you and the millions of people who visit this website every year. But we can’t do it alone.

Every donation helps fund reliable cancer information, compassionate support services and the most promising research. Please give today because every contribution counts. Thank you.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on cancer.ca, nor do we endorse any service, product, treatment or therapy.


1-888-939-3333 | cancer.ca | © 2025 Canadian Cancer Society